Literature DB >> 17374459

A possible role of LIM mineralization protein 1 in tertiary dentinogenesis of dental caries treatment.

Xiao-Ying Wang1, Qi Zhang, Zhi Chen.   

Abstract

Dental caries is a slowly progressive infectious disease with high risks. In response to dental caries stimuli, the tertiary dentin might be formed, protecting the dental pulp. Tertiary dentinogenesis contributes greatly to the treatment of carious lesions as well as the preservation and restoration of entire tooth function. A number of studies have found that application of exogenous growth factors such as transforming growth factors and bone morphogenetic proteins on unexposed pulps are able to signal tertiary dentinogenesis. Since precise mechanism of tertiary dentinogenesis is still not clear, more potential signaling factors might contribute to this process. Dentinogenesis shares many similarities with osteogenesis. The factors involved in osteogenesis and bone repair such as bone morphogenetic proteins 2, 7 and core binding factor alpha1 play important roles in dentinogenesis. LIM mineralization protein 1 is a critical positive regulator of osteoblast differentiation, bone formation and repair. It is logical to postulate that LIM mineralization protein 1 might be involved in odontoblast differentiation and dentin formation both in normal and in pathological conditions. Application of LIM mineralization protein 1 might be a promising approach for inducing tertiary dentinogenesis in dental caries treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374459     DOI: 10.1016/j.mehy.2007.01.031

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  8 in total

1.  A comparative evaluation of the blood clot, platelet-rich plasma, and platelet-rich fibrin in regeneration of necrotic immature permanent teeth: A clinical study.

Authors:  Isha Narang; Neelam Mittal; Navin Mishra
Journal:  Contemp Clin Dent       Date:  2015 Jan-Mar

2.  Screening of aqueous extracts of medicinal herbs for antimicrobial activity against oral bacteria.

Authors:  Nam-Hui Yim; Young Pil Jung; Won-Kyung Cho; Taesoo Kim; Aeyung Kim; Minju Im; Jin Yeul Ma
Journal:  Integr Med Res       Date:  2013-02-09

3.  LIM mineralization protein-1 inhibits IL-1β-induced human chondrocytes injury by altering the NF-κB and MAPK/JNK pathways.

Authors:  Dijun Ou; Sheng Liu; Changjun Tong; Hezhong Tan; Yadong Yang; Chunlei He
Journal:  Exp Ther Med       Date:  2021-11-21       Impact factor: 2.447

4.  LIM Mineralization Protein-1 Enhances the Committed Differentiation of Dental Pulp Stem Cells through the ERK1/2 and p38 MAPK Pathways and BMP Signaling.

Authors:  Rui Mu; Bo Chen; Bo Bi; Hongchuan Yu; Juan Liu; Junxia Li; Maodian He; Liang Rong; Bingyao Liu; Ke Liu; Lei Zhu; Xiaolei Shi; Yi Shuai; Lei Jin
Journal:  Int J Med Sci       Date:  2022-07-18       Impact factor: 3.642

5.  Kaurenoic Acid from Aralia continentalis Inhibits Biofilm Formation of Streptococcus mutans.

Authors:  Seung-Il Jeong; Beom-Su Kim; Ki-Suk Keum; Kwang-Hee Lee; Sun-Young Kang; Bok-Im Park; Young-Rae Lee; Yong-Ouk You
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

6.  Inhibitory Effects of Chrysanthemum boreale Essential Oil on Biofilm Formation and Virulence Factor Expression of Streptococcus mutans.

Authors:  Beom-Su Kim; Sun-Ju Park; Myung-Kon Kim; Young-Hoi Kim; Sang-Bong Lee; Kwang-Hee Lee; Na-Young Choi; Young-Rae Lee; Young-Eun Lee; Yong-Ouk You
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-11       Impact factor: 2.629

7.  Composition Analysis and Inhibitory Effect of Sterculia lychnophora against Biofilm Formation by Streptococcus mutans.

Authors:  Yang Yang; Bok-Im Park; Eun-Hee Hwang; Yong-Ouk You
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-17       Impact factor: 2.629

8.  New Pyrimidinone-Fused 1,4-Naphthoquinone Derivatives Inhibit the Growth of Drug Resistant Oral Bacteria.

Authors:  Kyungmin Kim; Daseul Kim; Hyunjin Lee; Tae Hoon Lee; Ki-Young Kim; Hakwon Kim
Journal:  Biomedicines       Date:  2020-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.